These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36508934)

  • 1. Correlations between single nucleotide polymorphisms in obsessive-compulsive disorder with the clinical features or response to therapy.
    Beheshti M; Rabiei N; Taghizadieh M; Eskandari P; Mollazadeh S; Dadgostar E; Hamblin MR; Salmaninejad A; Emadi R; Mohammadi AH; Mirazei H
    J Psychiatr Res; 2023 Jan; 157():223-238. PubMed ID: 36508934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of the role of serotonin system genes in obsessive-compulsive disorder.
    Sinopoli VM; Burton CL; Kronenberg S; Arnold PD
    Neurosci Biobehav Rev; 2017 Sep; 80():372-381. PubMed ID: 28576508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OLIG2 gene polymorphisms are associated with nasty, unpleasant and uncontrollable thoughts in obsessive-compulsive disorder.
    Vieira-Fonseca T; Fontenelle LF; Kohlrausch FB
    J Clin Neurosci; 2019 Dec; 70():202-207. PubMed ID: 31431405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The need for inclusion of sex and age of onset variables in genetic association studies of obsessive-compulsive disorder: Overview.
    Mattina GF; Steiner M
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jun; 67():107-16. PubMed ID: 26827635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catechol-O-methyltransferase gene Val158Met polymorphism and obsessive compulsive disorder susceptibility: a meta-analysis.
    Kumar P; Rai V
    Metab Brain Dis; 2020 Feb; 35(2):241-251. PubMed ID: 31879835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder.
    Wu K; Hanna GL; Rosenberg DR; Arnold PD
    Pharmacol Biochem Behav; 2012 Feb; 100(4):726-35. PubMed ID: 22024159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mindfulness-based cognitive therapy as an augmentation treatment for obsessive-compulsive disorder.
    Key BL; Rowa K; Bieling P; McCabe R; Pawluk EJ
    Clin Psychol Psychother; 2017 Sep; 24(5):1109-1120. PubMed ID: 28194835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and pharmacogenetic study of glutamate transporter (SLC1A1) in Iranian patients with obsessive-compulsive disorder.
    Abdolhosseinzadeh S; Sina M; Ahmadiani A; Asadi S; Shams J
    J Clin Pharm Ther; 2019 Feb; 44(1):39-48. PubMed ID: 30315580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Deep brain stimulation can break vicious circle in obsessive-compulsive disorder].
    Chen LL; Schechtmann G; Ring P; Djurfeldt D
    Lakartidningen; 2016 May; 113():. PubMed ID: 27219079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obsessive-compulsive disorder.
    George MS
    Int Clin Psychopharmacol; 1991 Dec; 6 Suppl 3():57-66; discussion 66-8. PubMed ID: 1806635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obsessive-Compulsive Disorder.
    Richter PMA; Ramos RT
    Continuum (Minneap Minn); 2018 Jun; 24(3, BEHAVIORAL NEUROLOGY AND PSYCHIATRY):828-844. PubMed ID: 29851880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology.
    Korff S; Harvey BH
    Psychiatr Clin North Am; 2006 Jun; 29(2):371-90. PubMed ID: 16650714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A genetic family-based association study of OLIG2 in obsessive-compulsive disorder.
    Stewart SE; Platko J; Fagerness J; Birns J; Jenike E; Smoller JW; Perlis R; Leboyer M; Delorme R; Chabane N; Rauch SL; Jenike MA; Pauls DL
    Arch Gen Psychiatry; 2007 Feb; 64(2):209-14. PubMed ID: 17283288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BDNF association study with obsessive-compulsive disorder, its clinical characteristics, and response to fluvoxamine-treatment in Iranian patients.
    Abdolhosseinzadeh S; Alizadeh N; Shams J; Asadi S; Ahmadiani A
    Exp Clin Psychopharmacol; 2020 Apr; 28(2):216-224. PubMed ID: 31180700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder.
    Arnold PD; Sicard T; Burroughs E; Richter MA; Kennedy JL
    Arch Gen Psychiatry; 2006 Jul; 63(7):769-76. PubMed ID: 16818866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disorder-specific genetic factors in obsessive-compulsive disorder: A comprehensive meta-analysis.
    Taylor S
    Am J Med Genet B Neuropsychiatr Genet; 2016 Apr; 171B(3):325-32. PubMed ID: 26616111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypochondriasis and its relationship to obsessive-compulsive disorder.
    Fallon BA; Qureshi AI; Laje G; Klein B
    Psychiatr Clin North Am; 2000 Sep; 23(3):605-16. PubMed ID: 10986730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder.
    Dickel DE; Veenstra-VanderWeele J; Cox NJ; Wu X; Fischer DJ; Van Etten-Lee M; Himle JA; Leventhal BL; Cook EH; Hanna GL
    Arch Gen Psychiatry; 2006 Jul; 63(7):778-85. PubMed ID: 16818867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The current status of association studies in obsessive-compulsive disorder.
    Hemmings SM; Stein DJ
    Psychiatr Clin North Am; 2006 Jun; 29(2):411-44. PubMed ID: 16650716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disgust in contamination-based obsessive-compulsive disorder: a review and model.
    Brady RE; Adams TG; Lohr JM
    Expert Rev Neurother; 2010 Aug; 10(8):1295-305. PubMed ID: 20662755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.